Hilary Kenny to Antibodies, Monoclonal
This is a "connection" page, showing publications Hilary Kenny has written about Antibodies, Monoclonal.
Connection Strength
0.129
-
Urokinase plasminogen activator system-targeted delivery of nanobins as a novel ovarian cancer therapy. Mol Cancer Ther. 2013 Dec; 12(12):2628-39.
Score: 0.071
-
Targeting the urokinase plasminogen activator receptor inhibits ovarian cancer metastasis. Clin Cancer Res. 2011 Feb 01; 17(3):459-71.
Score: 0.058